Product Information

LYRICA 75 MG CAPSULE is a brand product labeled by Viatris Specialty LLC, priced at $9.6740 per EA under NDC 58151023877. Its NADAC has been published 56 times since Jul 30, 2025.

FDA first approved this application on Dec 30, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the PREGABALIN market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LYRICA 75 MG CAPSULE

PREGABALIN
$9.6740per EA
High Outlier
DEA Schedule CV

Strength

75 mg/1

NDC

58151023877

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PREGABALIN

Approval Type

New Drug (NDA)

FDA Application

NDA021446

FDA Approved

12/30/2004

TE Code

AB

On Market Since

6/17/2025

Price Statistics

The NADAC for LYRICA 75 MG CAPSULE has been published 56 times since Jul 30, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$9.6740 per EA
All-time high$9.7419 (Nov 12, 2025)
All-time low$9.6728 (Jul 22, 2026)
52-week high$9.7419
52-week low$9.6728
Median price$9.7300
Average price$9.7138
Largest weekly change-0.6% (Nov 19, 2025)
Weeks tracked56
Tracking sinceJul 30, 2025

Price History

1W

+0.0%

1M

-0.0%

3M

-0.0%

6M

-0.6%

1Y

-0.6%

3Y

N/A

5Y

N/A

All

-0.6%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of LYRICA 75 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LYRICA 75 MG CAPSULE, manufactured by Viatris Specialty LLC, is $9.6740 per EA (NDC 58151023877), effective Aug 19, 2026.

How has the price of LYRICA 75 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for LYRICA 75 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 56 weekly CMS publications since Jul 30, 2025.

What are the highest and lowest recorded NADAC prices for LYRICA 75 MG CAPSULE?

Since Jul 30, 2025, the NADAC for LYRICA 75 MG CAPSULE has ranged from a low of $9.6728 (Jul 22, 2026) to a high of $9.7419 (Nov 12, 2025), with a median of $9.7300 per EA.

Are there cheaper alternatives to LYRICA 75 MG CAPSULE?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PREGABALIN 75 MG CAPSULE, is $0.0505 per EA — about 99% below LYRICA 75 MG CAPSULE.

Who manufactures LYRICA 75 MG CAPSULE?

LYRICA 75 MG CAPSULE (NDC 58151023877) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.